Phenomix Sciences
BIPOC-owned Phenomix Sciences was established by two leading NIH-funded obesity experts from the Mayo Clinic to bring precision medicine to obesity.
Its first product is a novel blood test supported by an AI-driven algorithm that classifies patients’ unique pathophysiological phenotype with obesity. The test results can be applied clinically by healthcare providers to guide the selection of more effective interventions for their patients and improve overall weight-loss outcomes using existing FDA-approved medications and devices.
Initial data from clinical trials at the Mayo Clinic show that with a phenotype-guided approach, the response rate to medication-based interventions is greater than 70%, which drives 2.3 times more weight loss than the current standard of care.